2015
DOI: 10.1155/2015/523896
|View full text |Cite
|
Sign up to set email alerts
|

Inducible Lentivirus‐Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Abstract: Although bone cancer pain is still not fully understood by scientists and clinicians alike, studies suggest that toll like receptor 4 (TLR4) plays an important role in the initiation and/or maintenance of pathological pain state in bone cancer pain. A promising treatment for bone cancer pain is the downregulation of TLR4 by RNA interference; however, naked siRNA (small interference RNA) is not effective in long-term treatments. In order to concoct a viable prolonged treatment for bone cancer pain, an inducible… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 35 publications
(42 reference statements)
1
15
0
Order By: Relevance
“…Thus, TLR4 could exert a regulatory function in processing painful stimuli in this model of diet-induced visceral hypersensitivity. Our data are consistent with others studies showing central [ 35 39 , 52 ] and peripheral [ 53 , 54 ] alterations of TLR4 associated with several pathological pain states such as inflammatory, neuropathic and cancer pain. As TLR4 is primarily expressed within the CNS in microglial cells [ 15 ], further DIO mice showed enhanced CD11b expression in the PFC and the hippocampus, thus our results are in line with several studies supporting microglia activation as an important factor in the etiology of visceral pain [ 42 , 55 , 56 ].…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Thus, TLR4 could exert a regulatory function in processing painful stimuli in this model of diet-induced visceral hypersensitivity. Our data are consistent with others studies showing central [ 35 39 , 52 ] and peripheral [ 53 , 54 ] alterations of TLR4 associated with several pathological pain states such as inflammatory, neuropathic and cancer pain. As TLR4 is primarily expressed within the CNS in microglial cells [ 15 ], further DIO mice showed enhanced CD11b expression in the PFC and the hippocampus, thus our results are in line with several studies supporting microglia activation as an important factor in the etiology of visceral pain [ 42 , 55 , 56 ].…”
Section: Discussionsupporting
confidence: 93%
“…Protein levels of TLR4 were increased in DIO mice in the prefrontal cortex (t = 6.02; p<0.001, Fig 3A ) and the hippocampus (t = 2.85; p<0.05, Fig 3B ) when compared with lean mice. Other pathological pain states as inflammatory neuropathic and cancer pain have been associated with alterations of TLR4 at the spinal cord level [ 35 39 ]. However, spinal TLR4 expression has not been studied in a model of obesity-induced visceral hypersensitivity.…”
Section: Resultsmentioning
confidence: 99%
“…To examine the effects of Peli1 on the induction of neuropathic pain, mice were given 10 μl Peli1 shRNA (2 × 10 8 TU) or 10 μl scrambled shRNA (1 × 10 9 TU) 3 days prior to the beginning of CCI by intrathecal injection. The dosages of shRNA were selected based on previous reports [26,27]. Thermal hyperalgesia and mechanical allodynia were measured before and 3, 5, 7, 11, 14 days after CCI.…”
Section: Experimental Designmentioning
confidence: 99%
“…TLR4 plays a role in the development of OSAS, as increased expressions of TLR4 could be detected in monocytes extracted from patients with OSAS (Deng et al, ). To blind the target genes, RNA interference (RNAi) is an accurate and powerful gene‐silencing technique by small interfering RNAs (siRNAs), or short hairpin RNAs (shRNAs) (Lan et al, ; Pan et al, ). Few thorough investigations has been reported on blockers specific to TLR4 , and studies on regulating TLR4 expressions by siRNA method may bring new prospects (Wu et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…Targeting TLR4 through NF-κB signaling pathway could be stimulated by lipopolysaccharide (LPS) (Lan et al, 2010;Pan et al, 2015). Few thorough investigations has been reported on blockers specific to TLR4, and studies on regulating TLR4 expressions by siRNA method may bring new prospects (Wu et al, 2012).…”
mentioning
confidence: 99%